You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 10,272,079


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,272,079 protect, and when does it expire?

Patent 10,272,079 protects XPHOZAH and is included in one NDA.

This patent has fifty patent family members in twenty-seven countries.

Summary for Patent: 10,272,079
Title:NHE3-binding compounds and methods for inhibiting phosphate transport
Abstract:Provided are NHE3-binding and/or NHE3-modulating agents having activity as phosphate transport inhibitors, including inhibitors of phosphate transport in the gastrointestinal tract and the kidneys, and methods for their use as therapeutic or prophylactic agent.
Inventor(s):Carreras Christopher, Charmot Dominique, Jacobs Jeffrey W, Labonte Eric, Lewis Jason G.
Assignee:ARDELYX, INC.
Application Number:US14783983
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,272,079: A Detailed Analysis

Introduction

Patent 10,272,079, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully comprehend this patent, it is crucial to delve into its various components and the broader patent landscape.

Patent Overview

United States Patent 10,272,079 is a utility patent that covers a specific invention. Here, we will analyze the key elements of this patent, including the background, summary, detailed description, and claims.

Background of the Invention

The background section of the patent provides context about the existing technology and the problems it addresses. This section is essential for understanding the motivation behind the invention and how it improves upon prior art.

Summary of the Invention

The summary section gives a brief overview of the invention, highlighting its main features and advantages. This section helps in quickly grasping the core of the invention without delving into the detailed description.

Detailed Description of the Invention

This section provides a thorough explanation of the invention, including its components, how it works, and any specific embodiments. It is here that the inventor describes the invention in enough detail to enable a person skilled in the art to make and use the invention.

Claims

The claims are the most critical part of a patent as they define the scope of protection. Here, we will analyze the different types of claims and how they apply to Patent 10,272,079.

Independent Claims

Independent claims stand alone and do not rely on other claims. They define the broadest scope of the invention and are often the most important claims in a patent.

Dependent Claims

Dependent claims build upon independent claims and narrow down the scope. They often add specific details or limitations to the independent claims, making them more specific.

Claim Analysis

To understand the scope of Patent 10,272,079, let's analyze an example of how claims are structured and what they mean.

Example of Claim Structure

  • Independent Claim: This claim might describe the overall system or method of the invention.
    • Example: "A method for processing audio signals, comprising: collecting audio data, separating the audio data into components, and using the separated components in a speech recognition system."
  • Dependent Claim: This claim adds specific details to the independent claim.
    • Example: "The method of claim 1, wherein the separated audio components are used in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments."

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patent eligibility is particularly relevant when analyzing the claims of Patent 10,272,079. This update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

Practical Applications

For a claim to be patent-eligible, it must integrate an abstract idea into a practical application. For instance, if the claim merely uses a mathematical model to manipulate data without any specific application, it would not be patent-eligible. However, if the claim specifies the use of the data in a real-time speech recognition system, it would meet the criteria for patent eligibility.

AI-Assisted Inventions

The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Patent Scope and Breadth

The scope of a patent is crucial in determining its validity and enforceability. Metrics such as independent claim length and independent claim count can be used to measure patent scope, as these metrics have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

Narrow vs. Broad Claims

Narrower claims are often associated with a higher probability of grant and a shorter examination process. Broad claims, while desirable for broader protection, can lead to increased licensing and litigation costs due to their potential ambiguity and overbreadth[3].

Patent Search and Examination

To understand the landscape around Patent 10,272,079, it is essential to conduct thorough patent searches. The USPTO provides several tools for this purpose, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs)[4].

Prior Art and Citation Data

Tools like the Common Citation Document (CCD) consolidate prior art cited by participating offices, helping to visualize search results for the same invention on a single page. This is crucial for ensuring that the patent does not infringe on existing patents and for identifying potential challenges during the examination process[4].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving. For example, the discussion around a small claims patent court highlights the need for more accessible and efficient dispute resolution mechanisms for patent holders[5].

Small Claims Patent Court

The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility of a small claims patent court, which could provide a more streamlined and cost-effective way for resolving patent disputes, especially for small inventors and businesses[5].

Real-World Applications and Benefits

To bolster the argument for patent eligibility, it is crucial to highlight the real-world applications and benefits of the claimed method or system. For instance, if the invention improves noise reduction in audio processing or enhances the accuracy of real-time speech recognition, these tangible benefits can demonstrate a clear technological improvement[1].

Key Takeaways

  • Practical Applications: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • AI-Assisted Inventions: The use of AI in invention development does not affect subject matter eligibility.
  • Claim Structure: Independent and dependent claims define the scope of protection, with narrower claims often being more favorable.
  • Patent Scope: Metrics like claim length and count can measure patent scope and its implications.
  • Patent Search: Thorough searches using USPTO tools are essential for understanding the patent landscape.
  • Legal Considerations: Evolving legal and policy frameworks, such as the potential for a small claims patent court, can impact patent enforcement and dispute resolution.

FAQs

What is the significance of practical applications in patent claims?

Practical applications are crucial for ensuring that claims integrate abstract ideas into tangible, real-world uses, thereby making them patent-eligible.

How does the use of AI affect patent eligibility?

The use of AI in the development of an invention does not impact its subject matter eligibility. The focus remains on the claimed invention itself.

What are the benefits of narrower claims in a patent?

Narrower claims are associated with a higher probability of grant and a shorter examination process, reducing the risk of ambiguity and litigation.

What tools does the USPTO provide for patent searches?

The USPTO offers tools such as the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) for conducting thorough patent searches.

Why is there a discussion about a small claims patent court?

A small claims patent court is being considered to provide a more accessible and cost-effective way for resolving patent disputes, particularly for small inventors and businesses.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Claims and Patent Scope - SSRN.
  4. Search for patents - USPTO - USPTO.
  5. U.S. Patent Small Claims Court - ACUS.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,272,079

Showing 1 to 6 of 6 entries

International Family Members for US Patent 10,272,079

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 095852 ⤷  Try for Free
Australia 2014250956 ⤷  Try for Free
Australia 2019204676 ⤷  Try for Free
Brazil 112015025805 ⤷  Try for Free
Canada 2909169 ⤷  Try for Free
China 105392483 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.